1217 Cloverlawn Ave
DISCLAIMER: The information contained on this website is not investment advice. Any specific securities or description of composition of securities listed or discussed do not represent any or all investments purchased, sold or recommended for advisory clients. One should not assume that any investments identified are or will be profitable. Targeted portfolio composition or strategy are not indicative of actual or future portfolio characteristics and there can be no assurance that the target portfolio characteristics will be achieved. There can be no guarantee that past performance is indicative of future results. No representation is being made that you will achieve profits or losses. Any investment involves substantial risk, including risk of loss. NO OFFER OF SECURITIES: Under no circumstances should any material on this site be used or considered as an offer to sell or a solicitation of any offer to buy an interest in any securities. The material on this website does not constitute, and may not be used in connection with, an offer or solicitation by anyone in any jurisdiction in which such offer or solicitation is not permitted by law or in which the person making such offer or solicitation is not qualified to do so or to any person to whom it is unlawful to make such offer or solicitation.
DISCLAIMER: This is a speculative investment and involves a high degree of risk. The company is in its development stage, has a limited operating history and is subject to the risks inherent in a new business enterprise. An investor should not purchase any securities unless they are prepared to lose their entire investment. the securities have not been registered under the securities act, or any state securities laws or the laws of any foreign jurisdiction. The securities have not been approved or disapproved by the securities regulatory authority of any state or by the United States securities and exchange commission, nor has any authority or commission passed upon the accuracy or adequacy of this memorandum or any other literature furnished to prospective investors in connection with the offering. any representation to the contrary is unlawful.